Crossmark Global Holdings’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,217
Closed -$261K 1318
2023
Q3
$261K Buy
1,217
+11
+0.9% +$2.2K 0.01% 1082
2023
Q2
$232K Sell
1,206
-32
-3% -$6.36K 0.01% 1189
2023
Q1
$250K Buy
+1,238
New +$199K 0.01% 1127
2022
Q3
Sell
-1,351
Closed -$239K 1288
2022
Q2
$239K Buy
+1,351
New +$195K 0.01% 1147
2021
Q4
Sell
-2,891
Closed -$491K 1490
2021
Q3
$491K Buy
+2,891
New +$450K 0.01% 933
2018
Q4
Sell
-3,405
Closed -$263K 1579
2018
Q3
$263K Buy
3,405
+40
+1% +$2.95K 0.01% 1403
2018
Q2
$223K Buy
+3,365
New +$193K 0.01% 1488
2018
Q1
Sell
-5,090
Closed -$272K 1637
2017
Q4
$272K Buy
5,090
+55
+1% +$3.21K 0.01% 1426
2017
Q3
$274K Buy
+5,035
New +$258K 0.01% 1375
2016
Q3
$274K Buy
+5,035
New +$239K 0.01% 1375

Other funds holding SGEN

Crossmark Global Holdings's SGEN Position: Q4 2023 in Review

Crossmark Global Holdings sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 1,217 shares — an estimated $261K sold.

Crossmark Global Holdings first reported a position in SGEN in Q3 2016 and held it in 10 quarters. The position peaked at $491K in Q3 2021. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Crossmark Global Holdings reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Crossmark Global Holdings sold 1,217 Seagen Inc. Common Stock shares in Q4 2023, an estimated $261K.
  • Crossmark Global Holdings first reported a position in Seagen Inc. Common Stock in Q3 2016 and held it in 10 quarters.
  • Crossmark Global Holdings's Seagen Inc. Common Stock position peaked at $491K in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Crossmark Global Holdings's 13F filing for Q4 2023, filed 13 Feb 2024.